The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Travel stocks soar as encouraging vaccine study lifts Europe

Wed, 15th Jul 2020 09:41

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* Euro zone blue-chips hit highest since March 5

* Italy's Atlantia soars as end of concession dispute nears

* Sweden's SEB slips as loan loss provision surges

* All eyes on ECB meeting, EU summit later this week
(Updates to market close)

By Sruthi Shankar

July 15 (Reuters) - European stocks closed at over a
five-week high on Wednesday, with travel stocks surfing a wave
of optimism following reports of progress in developing a
COVID-19 vaccine.

Hard-hit airline stocks like British Airways-owner IAG
, Ryanair and Lufthansa rose between
9.7% and 10.7%, while cruise operator Carnival Plc
jumped 11.4%.

The travel & leisure index surged 6.1% to lead
sectoral gains, but still remains the worst performer in Europe
this year with a 33% plunge as the coronavirus pandemic brought
global travel to a halt.

The pan-European STOXX 600 rose 1.8%, closing just
short of levels last seen in early March, while euro zone
blue-chips jumped 1.7% to hit their highest level
since March 5.

Investors were encouraged by an early-stage study on U.S.
biotech firm Moderna Inc's experimental vaccine for
COVID-19 that provoked immune responses.

Meanwhile, AstraZeneca jumped 5.2% after a report
said positive news on the University of Oxford's potential
COVID-19 vaccine that has been licensed to the drugmaker could
be announced as soon as Thursday.

"Our central scenario is that a vaccine would be broadly
available from the second quarter of next year, or the fourth
quarter of this year in our upside scenario," Mark Haefele,
chief investment officer of UBS Global Wealth Management, told
clients.

"Various potential treatment options are also in the
pipeline, raising hopes that societies can cope with the
pandemic without full shutdowns."

Expectations were also high among investors heading into an
EU summit later this week that leaders will agree on a recovery
fund of 750 billion euros for pandemic-hammered economies.

The European Central Bank concludes its policy meeting on
Thursday although no major announcements are expected.

Among individual movers, Swedish telecom operator Tele2 AB
gained 2.9% as it reaffirmed its 2020 earnings
outlook and plans for an extra shareholder payout.

The world's largest fish farmer Mowi ASA jumped
6.8% as harvest volumes beat its own forecast. Shares in peer
Salmar rose 2.2%.

The top gainer on the STOXX 600 was Atlantia SpA,
which shot up 26.7% after the Italian infrastructure group and
its unit Autostrade made the government new offers to settle
their long-running dispute.

Semiconductor equipment maker ASML Holding NV
declined 3.7% as it reported quarterly profit below estimates,
but forecast overall growth for 2020.

Swedish bank SEB AB fell 1.6% after reporting a
smaller-than-expected fall in net quarterly profit, but credit
loss provisions surged. Handelsbanken AB also dropped
2.6%.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Shounak
Dasgupta and Catherine Evans)

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.